Here's what Wall Street expects from Enanta Pharmaceuticals's earnings

  • On February 7, Enanta Pharmaceuticals will report earnings from Q1.
  • Wall Street predict expect Enanta Pharmaceuticals will release losses per share of $1.598.
  • Go here to track Enanta Pharmaceuticals stock price in real-time on Markets Insider.

Enanta Pharmaceuticals is reporting earnings from the last quarter on February 7.

6 analysts expect losses of $1.598 per share as opposed to losses of $1.480 per share in the same quarter of the previous year.

Wall Street is expecting the company to report $22.5 million, an decrease of 18.70% over the prior year quarter when the company reported $27.7 million.

For the fiscal year, analysts expect losses per share of $6.245 compared to $-5.910 in the previous year. On average, they are expecting revenue to come in at $130.4 million, compared to $ 86.2 million last year.

This story was written by Markets Insider’s RoboEddy, which automatically writes these stories based on data provided by our partners.